Sanigen세니젠
188260 · KOSDAQ · ₩188260 · 세니젠
₩1,923▼ ₩112 (5.50%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | ₩15B | ₩15B | ₩20B |
| Cost of sales | ₩12B | ₩13B | ₩17B |
| Gross profit | ₩3.1B | ₩2.4B | ₩2.9B |
| Operating income | −₩4.4B | −₩5.9B | −₩6.5B |
| Net income | −₩5.8B | −₩6.6B | −₩9.2B |
| Net income to shareholders | −₩5.8B | −₩6.6B | −₩9.2B |
Balance sheet
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total assets | ₩10B | ₩15B | ₩21B |
| Current assets | ₩6.2B | ₩9.9B | ₩16B |
| Cash and equivalents | ₩1.6B | ₩5.5B | ₩2.5B |
| Total liabilities | ₩7.6B | ₩6.4B | ₩7.6B |
| Current liabilities | ₩3.8B | ₩2.4B | ₩2.6B |
| Borrowings | ₩2.1B | ₩1.6B | ₩2.9B |
| Total equity | ₩2.5B | ₩8.2B | ₩13B |
| Shareholders' equity | ₩2.5B | ₩8.2B | ₩13B |
Cash flow
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Cash from operations | −₩4.2B | −₩5.4B | −₩3.8B |
| Free cash flow | −₩4.2B | −₩5.4B | −₩3.8B |
Consolidated where available. Amounts in won.
Also known as: Sanigen / 세니젠 / 188260 / KRX:188260
Source: KRX statistical information